This inventor holds 6 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Oncoceutics, Inc., Supernus Pharmaceuticals, Inc.. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Yanjun Sun: Innovator in Pharmaceutical Chemistry
Introduction
Yanjun Sun is a prominent inventor based in Kendall Park, NJ (US), known for her significant contributions to pharmaceutical chemistry. With a total of 6 patents, she has made remarkable strides in developing compounds that address critical health issues.
Latest Patents
Among her latest patents, Yanjun Sun has developed substituted derivatives of isoindoles. These compounds, specifically 5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol, along with their stereoisomers and pharmaceutically acceptable salts, are designed for use in pharmaceutical compositions aimed at treating central nervous system diseases or disorders. Additionally, she has worked on 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one and its analogs, which are intended for therapeutic applications, including cancer treatment.
Career Highlights
Yanjun Sun has held positions at notable companies such as Oncoceutics, Inc. and Supernus Pharmaceuticals, Inc. Her work in these organizations has been pivotal in advancing research and development in the pharmaceutical sector.
Collaborations
Throughout her career, Yanjun has collaborated with esteemed colleagues, including Bhaskara Rao Nallaganchu and Gary Olson. These partnerships have contributed to her innovative research and the successful development of her patented compounds.
Conclusion
Yanjun Sun's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.